Lilie Lin, MD
Enriched profileProfessor, Radiation Oncology · The University of Texas MD Anderson Cancer Center
Lilie Lin is Professor, Radiation Oncology at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 256 publications with 4,057 citations (h-index 34); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 28 Oct 2026
Lilie Lin, MD, is Professor, Radiation Oncology at The University of Texas MD Anderson Cancer Center. The public record shows 256 publications with 4,057 citations (h-index 34), centered on Endometrial and Cervical Cancer Treatments, Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 4 companies, 2 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · JCO global oncology
- Top research focus: Endometrial and Cervical Cancer Treatments
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 72.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Sponsor: Washington University School of Medicine
- Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
Sponsor: M.D. Anderson Cancer Center
- Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
Sponsor: M.D. Anderson Cancer Center
Industry payments
Updated 28 Oct 2026
4 companies reported payments to CMS in program years 2023–2024. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20241 payment
- Elekta, Inc.Program year20231 payment
- Telix PharmaceuticalsProgram year20231 payment
NIH funding
Updated 28 Oct 2026
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
University of Tx Md Anderson Can Ctr
FY2026$663,372R01CA284623 - The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
University of Tx Md Anderson Can Ctr
FY2026$68,809R01CA284623 - The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
University of Tx Md Anderson Can Ctr
FY2026$27,996R01CA284623
Congress activity
Updated 28 Oct 2026
43 congress contributions (2004–2025) across AACR, ASCO, ASTRO per OpenAlex. The most recent:
- Management of De-Novo Stage IVB Cervical Cancer with Induction Chemotherapy Followed by Definitive Chemoradiation
ASTRO Annual Meeting
ASTRO2025Co-author - Outcomes of Patients with Gastric-Type Adenocarcinoma of the Uterine Cervix after Definitive or Adjuvant Chemoradiotherapy
ASTRO Annual Meeting
ASTRO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Baseline PARP-1 PET imaging in patients with advanced solid tumors with DNA damage response mutations.
European journal of nuclear medicine and molecular imaging
Article2026 - Use of Interactive, Patient-Centric Mobile Health Technology in Sub-Saharan Africa: A Scoping Review.
JCO global oncology
Article2025 - Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: Ipabalele study results.
JNCI cancer spectrum
Article2025 - Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation.
Clinical cancer research
Article2025
Most-cited works
by citation count (OpenAlex)- 01Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice GuidelineArticle315 citations2020
- 02
- 03HIV Infection and Survival Among Women With Cervical CancerArticle202 citations2016
- 04
- 05A Systematic Review of Radiotherapy Capacity in Low- and Middle-Income CountriesReview158 citations2015
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- Associate Medical Director
Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center
2026verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Media & interviews
press, podcasts and appearances- Podcast episode
International Journal of Gynecologic Cancer (IJGC) BMJ podcast: radiotherapy and novel agents in gynecologic cancers, with Lilie Lin
2020provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ijgcbmj.podbean.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute